Human Retinal Stem Cell Production
Possible commercial applications may include a use of the method to develop suitable cell types for cell-based therapy to treat retinal degeneration, disease in a dish modeling and drug screening.
UC San Diego investigators, Drs Kang Zhang, Jiagang Zhao and Adah Almutairi, have developed a rapid and efficient method to produce human multi-potent retinal cells under defined conditions. Remarkably, these cells can be directed toward a specific retinal cell fate in vitro, including RGCs, photoreceptors or RPE. Furthermore, multi-potent retinal cell transplants can survive and integrate and importantly differentiate into photoreceptors in the degenerating retina of RCS rats. This invention may provide a renewable source of cells for therapeutic applications in retinal regeneration.This invention may provide an efficient, cost effective, GMP applicable method for producing both neuronal and non-neuronal retinal cells.
20160243285
Tech ID/UC Case 23953/2014-061-0 Related Cases 2014-061-0
USA

